<DOC>
	<DOCNO>NCT01156337</DOCNO>
	<brief_summary>The study aim verify effect Hypertonic saline solution ( HSS ) moderate sodium ( Na ) restriction plus high furosemide dose short term ( hospitalization time ) moderate Na restriction long term readmission mortality patient III NYHA class .</brief_summary>
	<brief_title>Sodium Management Acute Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Decompensated HF due ischemic nonischemic cardiomyopathy , &gt; 18 year age , HF accord Framingham criterion NYHA functional class III EF &lt; 40 % , Serum creatinine &lt; 2,5 mg/dL BUN &lt; 60 mg/dL , Exclusion criterion : NYHA class &gt; III &lt; III , Cerebral vascular disease , Dementia , Cancer , Uncompensated diabetes , Severe hepatic disease Patients require pacemaker Previous RCT implantation Alcoholic habit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Heart failure III NYHA class</keyword>
	<keyword>Furosemide</keyword>
	<keyword>Sodium</keyword>
	<keyword>water restriction</keyword>
	<keyword>decompensated heart failure</keyword>
	<keyword>Hypertonic saline solution</keyword>
	<keyword>Moderate sodium restriction</keyword>
</DOC>